Insiders · Profile

MORNEAU MICHAEL

VP, Finance and Administration at Viking Therapeutics. Filing since 31 May 2018. CIK 0001517780

Company

Date

Role

Action

Amount

Of holding

31 May 2018

VP, Finance and Administration

Sold, plan not stated

21,551

$199.35K

18.6%

1 decision on file.